Outcomes Hematologic parameters | Model 1 HR (95% CI) | Model 2 HR (95% CI) |
---|---|---|
Retinopathy (n = 161) |  |  |
 Haemoglobin | 0.76 (0.64–0.90)†| 0.79 (0.66–0.95)‡ |
 RDW | 1.12 (0.97–1.29) | 1.15 (0.99–1.35) |
 Leukocytes | 1.13 (0.97–1.32) | 1.14 (0.97–1.33) |
 Neutrophyls | 1.06 (0.91–1.25) | 1.08 (0.92–1.26) |
 Lymphocytes | 1.10 (0.92–1.31) | 1.16 (0.97–1.38) |
 Monocytes | 1.05 (0.91–1.23) | 1.00 (0.85–1.18) |
 Platelets | 1.08 (0.91–1.28) | 1.08 (0.92–1.27) |
 Neutrophyl-to-lymphocyte ratio | 1.02 (0.87–1.21) | 0.98 (0.84–1.14) |
 Lymphocyte-to-monocyte ratio | 0.98 (0.83–1.16) | 1.08 (0.91–1.28) |
 Platelet-to-lymphocyte ratio | 0.95 (0.81–1.11) | 0.91 (0.77–1.08) |
 Monocyte-to-HDL ratio | 1.06 (0.91–1.23) | 1.01 (0.85–1.20) |
Renal composite (n = 206) |  |  |
 Haemoglobin | 0.87 (0.74–1.01) | 0.87 (0.74–1.02) |
 RDW | 1.02 (0.89–1.17) | 1.01 (0.88–1.17) |
 Leukocytes | 1.16 (1.01–1.33)‡ | 1.12 (0.97–1.29) |
 Neutrophyls | 1.15 (1.00–1.32)‡ | 1.11 (0.97–1.28) |
 Lymphocytes | 0.98 (0.84–1.16) | 0.99 (0.84–1.17) |
 Monocytes | 1.14 (1.00–1.30) | 1.11 (0.96–1.27) |
 Platelets | 1.05 (0.91–1.21) | 1.06 (0.92–1.23) |
 Neutrophyl-to-lymphocyte ratio | 1.11 (0.97–1.26) | 1.07 (0.94–1.23) |
 Lymphocyte-to-monocyte ratio | 0.90 (0.77–1.06) | 0.95 (0.81–1.11) |
 Platelet-to-lymphocyte ratio | 0.99 (0.86–1.14) | 1.00 (0.86–1.15) |
 Monocyte-to-HDL ratio | 1.15 (1.01–1.32)‡ | 1.11 (0.96–1.29) |
Microalbuminuria (n = 127) |  |  |
 Haemoglobin | 0.89 (0.74–1.08) | 0.88 (0.72–1.07) |
 RDW | 1.01 (0.84–1.22) | 1.02 (0.85–1.23) |
 Leukocytes | 1.16 (0.98–1.39) | 1.15 (0.96–1.38) |
 Neutrophyls | 1.18 (0.99–1.41) | 1.16 (0.97–1.40) |
 Lymphocytes | 0.99 (0.80–1.22) | 1.02 (0.82–1.26) |
 Monocytes | 1.11 (0.94–1.31) | 1.10 (0.92–1.30) |
 Platelets | 1.03 (0.86–1.23) | 1.03 (0.86–1.24) |
 Neutrophyl-to-lymphocyte ratio | 1.10 (0.93–1.30) | 1.07 (0.90–1.28) |
 Lymphocyte-to-monocyte ratio | 0.90 (0.74–1.10) | 0.93 (0.76–1.14) |
 Platelet-to-lymphocyte ratio | 0.97 (0.81–1.16) | 0.95 (0.79–1.14) |
 Monocyte-to-HDL ratio | 1.11 (0.93–1.32) | 1.10 (0.91–1.32) |
Renal failure (n = 104) |  |  |
 Haemoglobin | 0.75 (0.61–0.93)†| 0.79 (0.64–0.99)‡ |
 RDW | 1.07 (0.89–1.29) | 1.06 (0.88–1.28) |
 Leukocytes | 1.15 (0.94–1.41) | 1.09 (0.89–1.34) |
 Neutrophyls | 1.15 (0.95–1.40) | 1.11 (0.92–1.35) |
 Lymphocytes | 0.94 (0.75–1.19) | 0.93 (0.73–1.19) |
 Monocytes | 1.24 (1.03–1.49)‡ | 1.19 (0.97–1.45) |
 Platelets | 1.03 (0.84–1.28) | 1.04 (0.85–1.27) |
 Neutrophyl-to-lymphocyte ratio | 1.15 (0.96–1.38) | 1.11 (0.92–1.33) |
 Lymphocyte-to-monocyte ratio | 0.82 (0.64–1.04) | 0.86 (0.67–1.11) |
 Platelet-to-lymphocyte ratio | 1.01 (0.83–1.23) | 1.02 (0.84–1.24) |
 Monocyte-to-HDL ratio | 1.17 (0.97–1.43) | 1.09 (0.88–1.35) |
Peripheral neuropathy (n = 179) |  |  |
 Haemoglobin | 0.87 (0.71–1.06) | 1.19 (0.93–1.52) |
 RDW | 1.11 (0.92–1.35) | 0.85 (0.67–1.08) |
 Leukocytes | 1.16 (0.96–1.40) | 1.10 (0.89–1.37) |
 Neutrophyls | 1.19 (0.99–1.44) | 1.13 (0.90–1.40) |
 Lymphocytes | 0.91 (0.73–1.14) | 0.93 (0.72–1.20) |
 Monocytes | 1.00 (0.83–1.21) | 0.99 (0.80–1.23) |
 Platelets | 0.95 (0.78–1.16) | 0.93 (0.74–1.17) |
 Neutrophyl-to-lymphocyte ratio | 1.23 (1.02–1.49)‡ | 1.16 (0.92–1.45) |
 Lymphocyte-to-monocyte ratio | 0.90 (0.74–1.09) | 0.90 (0.72–1.12) |
 Platelet-to-lymphocyte ratio | 1.04 (0.86–1.26) | 1.00 (0.80–1.25) |
 Monocyte-to-HDL ratio | 1.05 (0.86–1.28) | 1.09 (0.86–1.38) |